The overexpression of miR-489 blocked pulmonary fibrosis both in vivo and in vitro by regulating its target genes MyD88 and Smad3, which are critical mediators in the inflammation and fibrotic signaling pathways, respectively. This evidence concerns the gene SMAD3 and pulmonary fibrosis.